Primary non-Hodgkin's lymphoma of the uterine cervix

Archives of Gynecology and Obstetrics

Volumn 265, Issue 2, 2001, Pages 108-111

  Yokoyama, Y ^a   Sato, S ^a   Xiao, Y H ^a   Tanaka, K ^a   Maruyama, H ^a   Saito, Y ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Non Hodgkin's lymphoma; Radiotherapy; Soluble interleukin 2 receptor; Uterine cervix

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; INTERLEUKIN 2 RECEPTOR; PREDNISOLONE; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; NONHODGKIN LYMPHOMA; TREATMENT OUTCOME; UTERINE CERVIX TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RADIOTHERAPY; RECEPTORS, INTERLEUKIN-2; REMISSION INDUCTION; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 0035021261     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004040000147     Document Type: Article

References (16)

1. Primary malignant lymphoma of the uterine cervix: Is radiotherapy the best therapeutic choice for stage IE?
2. Survival of patients with localized histiocytic lymphoma
3. Report of the committee on Hodgkin's disease staging classification
4. Increased level of soluble interleukin-2 receptor in non-Hodgkin's lymphomas
5. New gynecologic cancer staging
6. Malignant lymphoma and granulocytic sarcoma of the uterus and vagina
7. Pirarubicin, a novel derivative of doxorubicin. THP-COP therapy for non-Hodgkin's lymphoma in the elderly
8. Malignant lymphoma of the uterine cervix
9. Primary lymphoma of the uterine cervix
10. A case of primary non-Hodgkin's lymphoma of the uterine cervix treated by combination chemotherapy (THP-COP)
11. Lymphomas of the cervix and upper vagina: A report of five cases and a review of the literature
12. High serum interleukin-2 receptor levels are related to advanced disease and a poor outcome in childhood non-Hodgkin's lymphoma
13. Advances in adult non-Hodgkin's lymphoma
14. Soluble interleukin receptors are released from activated human lymphoid cells in vitro
15. The value of surgical removal of localized lymphomas
16. Soluble interleukin-2 receptor levels in patients with undifferented and lymphoblastic lymphomas: Correlation with survival